학술논문
'학술논문'
에서 검색결과 6,262건 | 목록
1~20
Academic Journal
Machiraju, Devayani; Ziener, Christian H; Clementi, Elena; García-Asencio, Francisco; Hüllein, Jennifer; Richter, Jasmin; Lenoir, Bénédicte; Wiecken, Melanie; Hübschmann, Daniel; Jäger, Dirk; Hassel, Jessica C
Report
A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects With Advanced Non-Small Cell Lung Cancer
Jatkoe T, Wang S, Odegaard JI, Velasco Roth AM, Osgood D, Martinez G, Lucas P, Curtin JC, Karkera J. Clinical Validation of Companion Diagnostics for the Selection of Patients with Non-Small Cell Lung Cancer Tumors Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutations for Treatment with Amivantamab. J Mol Diagn. 2022 Nov;24(11):1181-1188. doi: 10.1016/j.jmoldx.2022.07.003. Epub 2022 Aug 10.
Park K, Haura EB, Leighl NB, Mitchell P, Shu CA, Girard N, Viteri S, Han JY, Kim SW, Lee CK, Sabari JK, Spira AI, Yang TY, Kim DW, Lee KH, Sanborn RE, Trigo J, Goto K, Lee JS, Yang JC, Govindan R, Bauml JM, Garrido P, Krebs MG, Reckamp KL, Xie J, Curtin JC, Haddish-Berhane N, Roshak A, Millington D, Lorenzini P, Thayu M, Knoblauch RE, Cho BC. Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. J Clin Oncol. 2021 Oct 20;39(30):3391-3402. doi: 10.1200/JCO.21.00662. Epub 2021 Aug 2.
Kohler J, Janne PA. Amivantamab: Treating EGFR Exon 20-Mutant Cancers With Bispecific Antibody-Mediated Receptor Degradation. J Clin Oncol. 2021 Oct 20;39(30):3403-3406. doi: 10.1200/JCO.21.01494. Epub 2021 Aug 2. No abstract available.
Jatkoe T, Wang S, Odegaard JI, Velasco Roth AM, Osgood D, Martinez G, Lucas P, Curtin JC, Karkera J. Clinical Validation of Companion Diagnostics for the Selection of Patients with Non-Small Cell Lung Cancer Tumors Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutations for Treatment with Amivantamab. J Mol Diagn. 2022 Nov;24(11):1181-1188. doi: 10.1016/j.jmoldx.2022.07.003. Epub 2022 Aug 10.
Park K, Haura EB, Leighl NB, Mitchell P, Shu CA, Girard N, Viteri S, Han JY, Kim SW, Lee CK, Sabari JK, Spira AI, Yang TY, Kim DW, Lee KH, Sanborn RE, Trigo J, Goto K, Lee JS, Yang JC, Govindan R, Bauml JM, Garrido P, Krebs MG, Reckamp KL, Xie J, Curtin JC, Haddish-Berhane N, Roshak A, Millington D, Lorenzini P, Thayu M, Knoblauch RE, Cho BC. Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. J Clin Oncol. 2021 Oct 20;39(30):3391-3402. doi: 10.1200/JCO.21.00662. Epub 2021 Aug 2.
Kohler J, Janne PA. Amivantamab: Treating EGFR Exon 20-Mutant Cancers With Bispecific Antibody-Mediated Receptor Degradation. J Clin Oncol. 2021 Oct 20;39(30):3403-3406. doi: 10.1200/JCO.21.01494. Epub 2021 Aug 2. No abstract available.
Report
A Phase I/II Study of MCLA-129, a Human Anti-EGFR and Anti-c-Met Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors, Evaluating Safety, Pharmacokinetic Characteristics and Antitumor Activity
Academic Journal
Das, Biswajit; Sethy, Chinmayee; Chatterjee, Subhajit; Dash, Somya Ranjan; Sinha, Saptarshi; Paul, Subarno; Goutam, Kunal; Kundu, Chanakya Nath
Journal of Cell Communication and Signaling. 17(4):1371-1388
Academic Journal
Hook, Mary; Dailey, Mary Sue; Singh, Maharaj; Schneuker, Deimante; Mitchell, Linda; Milligan, Kerri; Mendoza, Gene; Dabu, Fortune; Kelly, Lynn
Academic Journal
Mckenna, Grace; Cruz, Cole; Simmons, Bryon; Brewster, James T.; Benz-Weeden, Anna M.; Brandt, Thomas A.; Bumpers, Quinn A.; Cook, Adam; Elsayed, Mohamed Saad Abdullah; Golec, Daniel; Lewandowski, Nicholas; Nguyen, Phong; Pipal, Robert W.; Savechenkov, Pavel; Wong, Christina E.; Tarlton, Eugene; Gaudino, John J.; Hinklin, Ronald J.; Tang, Tony P.
Academic Journal
Jiang, Wen G.; Ye, Lin; Ruge, Fiona; Owen, Sioned; Martin, Tracey; Sun, Ping‑Hui; Sanders, Andrew J.; Lane, Jane; Satherley, Lucy; Weeks, Hoi P.; Gao, Yong; Wei, Cong; Wu, Yiling; Mason, Malcolm D.
Journal of Translational Medicine. 22(1)
Academic Journal
Mourkogianni, Eleni; Karavasili, Katerina; Xanthopoulos, Athanasios; Enake, Michaela-Karina; Menounou, Lydia; Papadimitriou, Evangelia
Academic Journal
Chiawpanit, Chutipa; Wathikthinnakorn, Methi; Sawasdee, Nunghathai; Phanthaphol, Nattaporn; Sujjitjoon, Jatuporn; Junking, Mutita; Yamabhai, Montarop; Panaampon, Jutatip; Yenchitsomanus, Pa-thai; Panya, Aussara
In International Immunopharmacology 30 July 2024 136
Periodical
Obesity, Fitness & Wellness Week. July 12, 2025, 837
Academic Journal
Zhao, Yingchao; Liu, Pinan; Zhang, Na; Chen, Jie; Landegger, Lukas D.; Wu, Limeng; Zhao, Fu; Zhao, Yanxia; Zhang, Yanling; Zhang, Jing; Fujita, Takeshi; Stemmer-Rachamimov, Anat; Ferraro, Gino B.; Liu, Hao; Muzikansky, Alona; Plotkin, Scott R.; Stankovic, Konstantina M.; Jain, Rakesh K.; Xu, Lei
Proceedings of the National Academy of Sciences of the United States of America, 2018 Feb . 115(9), E2077-E2084.
Report
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, Nishio M, Thomas M, Ohashi K, Toyozawa R, Overbeck TR, de Marinis F, Kim TM, Laack E, Robeva A, Le Mouhaer S, Waldron-Lynch M, Sankaran B, Balbin OA, Cui X, Giovannini M, Akimov M, Heist RS; GEOMETRY mono-1 Investigators. Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N Engl J Med. 2020 Sep 3;383(10):944-957. doi: 10.1056/NEJMoa2002787.
Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, Nishio M, Thomas M, Ohashi K, Toyozawa R, Overbeck TR, de Marinis F, Kim TM, Laack E, Robeva A, Le Mouhaer S, Waldron-Lynch M, Sankaran B, Balbin OA, Cui X, Giovannini M, Akimov M, Heist RS; GEOMETRY mono-1 Investigators. Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N Engl J Med. 2020 Sep 3;383(10):944-957. doi: 10.1056/NEJMoa2002787.
Academic Journal
Zhongguo quanke yixue, Vol 27, Iss 27, Pp 3344-3350 (2024)
Academic Journal
Chen, Huihui; Le Sun; Hu, Bing; Zhao, Zhiping; Liu, Ziheng; Qiu, Guangbao; Bai, Dongmei; Li, Ying; Ren, Ziwei; Zhang, Ting; Ye, Xin; You, Lingfeng; Xue, Zhendong; Mao, Yuchang; Dang, Huaixin; Cai, Shuyu; Feng, Jun; Hu, Min; He, Feng
Academic Journal
Janzic, Urska; Shalata, Walid; Szymczak, Katarzyna; Dziadziuszko, Rafał; Jakopovic, Marko; Mountzios, Giannis; Płużański, Adam; Araujo, Antonio; Charpidou, Andriani; Agbarya, Abed
Report
Clinical Trial of Autologous cMET Redirected T Cells Administered Intravenously in Patients With Melanoma & Breast Carcinoma
Conference
2015 Innovation & Commercialization of Medical Electronic Technology Conference (ICMET) Innovation & Commercialization of Medical Electronic Technology Conference (ICMET), 2015. :68-73 Nov, 2015
Academic Journal
Lilin Li; Jung Nam An; Jeonghwan Lee; Dong Jin Shin; Shi Mao Zhu; Jin Hyuk Kim; Dong Ki Kim; Dong-ryeol Ryu; Sejoong Kim; Jung Pyo Lee
Kidney Research and Clinical Practice(구 대한신장학회지). Dec 31, 2021 40(4):596
검색 결과 제한하기
제한된 항목
[검색어] CMET
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어